Screener
Acumen Pharmaceuticals, Inc. ABOS Q1 2026 earnings
Reported May 12, 2026 · Before market open
EPS-$0.33Beat by $0.07
EPS estimate-$0.40
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.43
Versus estimates
Diluted EPS
FAQ
- When did Acumen Pharmaceuticals, Inc. report Q1 2026 earnings?
- Acumen Pharmaceuticals, Inc. (ABOS) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Acumen Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Acumen Pharmaceuticals, Inc. reported eps of $-0.33 for Q1 2026.
- Did Acumen Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.40 by $0.07.
- How did Acumen Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 31.2% from $-0.48.
- Where can I find Acumen Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-033868) and the 10-Q periodic report (0001628280-26-034204) directly on SEC EDGAR. The filing index links above go to sec.gov.
